Moreover, increased TAZ/YAP activity in poorly differentiated breast tumors were associated with enrichment of stem cell signature, suggesting that TAZ/YAP bestowed cancer stem cell-like properties on breast cancer cells [63]. Here, YAP1 is linked to breast carcinoma.